e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
The ageing pulmonary interstitium
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effect of erythropoietin (EPO) on cyclooxygenase-2 (COX-2) and cytochrome-c (CYT-c) in the bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats
D. Tsavlis, A. Tzoumaka, G. Kokaraki, K. Kouzi-Koliakos, I. Angomachalelis, A. Tektonidou, D. Koutsonikolas, E. Spandou (Thessaloniki, Greece)
Source:
Annual Congress 2011 - The ageing pulmonary interstitium
Session:
The ageing pulmonary interstitium
Session type:
Thematic Poster Session
Number:
791
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Tsavlis, A. Tzoumaka, G. Kokaraki, K. Kouzi-Koliakos, I. Angomachalelis, A. Tektonidou, D. Koutsonikolas, E. Spandou (Thessaloniki, Greece). The effect of erythropoietin (EPO) on cyclooxygenase-2 (COX-2) and cytochrome-c (CYT-c) in the bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats. Eur Respir J 2011; 38: Suppl. 55, 791
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Erythropoietin (EPO) attenuates the expression of its receptor (EPO-R) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
Erythropoietin (EPO) inhibits the immunohistochemical expression of lysyl oxidase (LOX) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Erythropoietin (EPO) attenuates the immunohistochemical expression of autophagy antibodies in bleomycin (BLM), induced pulmonary fibrosis (PF) in rats
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019
Erythropoietin (EPO) attenuates the immunohistochemical expression of tumor growth factor-ß (TGF-ß) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018
Erythropoietin (EPO) inhibits the bleomycin (BLM)-induced pulmonary fibrosis in rats
Source: Annual Congress 2010 - Emerging mechanisms in lung injury
Year: 2010
Effect of recombinant α-1 antitrypsin (rAAT) and TAPI on neutrophil elastase (NE) and matrix metalloproteinase-9 (MMP9) activity in induced sputum (IS) from healthy smokers and patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2003 - Progress on therapy for chronic obstructive pulmonary disease
Year: 2003
The attenuating effect of erythropoietin (EPO) on the expression of myeloperoxidase (MPO) in bleomycin-induced pulmonary fibrosis in rats
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Hepatocyte growth factor (HGF) expression in bronchoveolar lower (BAL) does not confirm its anti-fibrotic activity in interstitial lung diseases (ILD)
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012
Post-treatment with the heat shock protein 90 (hsp90) inhibitor, AUY-922, reduces lung hsp90 tyrosine (Y) phosphorylation and pulmonary inflammation in LPS-induced acute lung injury (ALI) in mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Production of matrix metalloprotease-9 (MMP-9) by alveolar macrophages (AMs) from smokers: effect of corticosteroids and phosphodiesterase inhibition
Source: Eur Respir J 2001; 18: Suppl. 33, 34s
Year: 2001
LSC 2013 abstract - NADPH oxidase isoform 2 (NOX2) is expressed in alveolar macrophages of emphysematous patients and prevents elastase-induced emphysema through the involvement of MMP9/TIMP1 gene expression
Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Year: 2013
The effect of switching cyclosporin A (CyA) to tacrolimus (FK) on exhaled nitric oxide (eNO) and pulmonary function in patients with chronic rejection after lung transplantation (LTx)
Source: Eur Respir J 2002; 20: Suppl. 38, 564s
Year: 2002
Increased nitric oxide synthase isoforms, endothelin 1 and apoptosis varied in lungs from patients with (SSc) and had impact on pulmonary function tests
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010
Roflumilast N-oxide (RNO) increases MAP kinase phosphatase-1 (MKP-1) expression in human lung fibroblasts (HLF)
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010
Mn-superoxide dismutase (Mn-SOD) is upregulated by N-acetylcysteine (NAC) administration in normal and septic rat diaphragms
Source: Eur Respir J 2004; 24: Suppl. 48, 333s
Year: 2004
Pulmonary tuberculosis (PT) in patients taking the TNF-a inhibitor inflixinab (INF)
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011
Treatment effects of Rho-kinase (Rock) inhibition
vs.
phosphodiesterase-5 (PDE5) inhibition on cardiac function and metabolism in monocrotaline induced pulmonary arterial hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 547s
Year: 2006
Expression of endothelial nitric oxide synthase (eNOS) and endothelin-1 (ET-1) in pulmonary arteries of patients with severe COPD
Source: Annual Congress 2003 - Pathophysiology of the pulmonary circulation
Year: 2003
Activation of membrane nadph oxidase in idiopathic pulmonary fibrosis (IPF) fibroblasts
Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept